Skip to main content
Erschienen in: AIDS and Behavior 4/2018

06.12.2017 | Original Paper

Strategies to Implement Pre-exposure Prophylaxis with Men Who Have Sex with Men in Ukraine

verfasst von: Alex Dubov, Liana Fraenkel, Roman Yorick, Adedotun Ogunbajo, Frederick L. Altice

Erschienen in: AIDS and Behavior | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Ukrainian men who have sex with men (MSM) remain highly stigmatized group with HIV prevalence as high as 23%. Despite documented effectiveness of pre-exposure prophylaxis (PrEP), PrEP remains unavailable in Ukraine. The aim of this study was to elicit MSM preferences in order to inform program development to facilitate successful delivery of PrEP to Ukrainian MSM. 1184 MSM were recruited through social networking applications to complete a stated preference (choice-based conjoint) survey. Respondents completed 14 choice tasks presenting experimentally-varied combinations of five attributes related to PrEP administration (dosing frequency, dispensing venue, prescription practices, adherence support, and costs). Latent class analysis was used to estimate the relative importance of each attribute and preferences across nine possible PrEP delivery programs. Preferences clustered into five groups. PrEP affordability was the most influential attribute across groups, followed by dosing strategy. Only one group preferred injectable PrEP (n = 216), while the other four groups disliked daily PrEP and strongly preferred the ‘on demand’ option. One group (n = 258) almost exclusively considered cost in their decision making. One group (n = 151) had very low level of interest in PrEP initiation correlated with low self-perceived risk for HIV. The two most at-risk groups (n = 415) were also more sensitive to changes in program delivery. PrEP uptake among MSM is most likely to be successful when PrEP is affordable, its implementation is targeted, provided as “on-demand” with associated education, and when more thorough medical care and related testing is provided to at-risk populations. Its introduction will need affirmation by the Ukrainian government, and guidelines that reflect safety, efficacy, and patient preferences.
Literatur
4.
Zurück zum Zitat Spindler H, Salyuk T, Vitek C, Rutherford G. Underreporting of HIV transmission among men who have sex with men in the Ukraine. AIDS Res Hum Retrovir. 2014;30(5):407–8.CrossRefPubMedPubMedCentral Spindler H, Salyuk T, Vitek C, Rutherford G. Underreporting of HIV transmission among men who have sex with men in the Ukraine. AIDS Res Hum Retrovir. 2014;30(5):407–8.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Bolshov YC, Kasyanczuk MG, Leschinskii YB, Trofimenko OV, Shvab IA. Monitoring of behavior and HIV prevalence among men having sex with men as a component of second generation HIV surveillance: analytical report on results of the linked survey of 2011. Kiev: ICF International HIV/AIDS Alliance in Ukraine; 2012 (in Ukrainian). Bolshov YC, Kasyanczuk MG, Leschinskii YB, Trofimenko OV, Shvab IA. Monitoring of behavior and HIV prevalence among men having sex with men as a component of second generation HIV surveillance: analytical report on results of the linked survey of 2011. Kiev: ICF International HIV/AIDS Alliance in Ukraine; 2012 (in Ukrainian).
8.
Zurück zum Zitat Bolshov YS, Kasyanczuk MG, Leschinskii YB, Trofimenko OV, Shvab IA. Monitoring of behavior and HIV prevalence among men having sex with men as a component of second generation HIV surveillance: analytical report on results of the linked survey of 2009. Kiev: ICF International HIV/AIDS Alliance in Ukraine; 2011 (in Ukrainian). Bolshov YS, Kasyanczuk MG, Leschinskii YB, Trofimenko OV, Shvab IA. Monitoring of behavior and HIV prevalence among men having sex with men as a component of second generation HIV surveillance: analytical report on results of the linked survey of 2009. Kiev: ICF International HIV/AIDS Alliance in Ukraine; 2011 (in Ukrainian).
10.
Zurück zum Zitat Bolshov YS, Kasianchuk MG, Leshchynskyi YB, Trofymenko LV, Shvab IA. Analytical report: behaviour monitoring and HIV-prevalence among men who have sex with men as a component of second generation surveillance. AIDS Alliance. 2012. Bolshov YS, Kasianchuk MG, Leshchynskyi YB, Trofymenko LV, Shvab IA. Analytical report: behaviour monitoring and HIV-prevalence among men who have sex with men as a component of second generation surveillance. AIDS Alliance. 2012.
11.
Zurück zum Zitat Zhou F, Gao L, Li S, Li D, Zhang L, Fan W, Yang X, Yu M, Xiao D, Yan L, Zhang Z. Willingness to accept HIV pre-exposure prophylaxis among Chinese men who have sex with men. PLoS ONE. 2012;7(3):e32329.CrossRefPubMedPubMedCentral Zhou F, Gao L, Li S, Li D, Zhang L, Fan W, Yang X, Yu M, Xiao D, Yan L, Zhang Z. Willingness to accept HIV pre-exposure prophylaxis among Chinese men who have sex with men. PLoS ONE. 2012;7(3):e32329.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat van Griensven F, Thienkrua W, Sukwicha W, Wimonsate W, Chaikummao S, Varangrat A, Mock PA. Sex frequency and sex planning among men who have sex with men in Bangkok, Thailand: implications for pre-and post-exposure prophylaxis against HIV infection. J Int AIDS Soc. 2010;13(1):13.CrossRefPubMedPubMedCentral van Griensven F, Thienkrua W, Sukwicha W, Wimonsate W, Chaikummao S, Varangrat A, Mock PA. Sex frequency and sex planning among men who have sex with men in Bangkok, Thailand: implications for pre-and post-exposure prophylaxis against HIV infection. J Int AIDS Soc. 2010;13(1):13.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Van der Elst EM, Mbogua J, Operario D, Mutua G, Kuo C, Mugo P, Kanungi J, Singh S, Haberer J, Priddy F, Sanders EJ. High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya. AIDS Behav. 2013;17(6):2162–72.CrossRefPubMedPubMedCentral Van der Elst EM, Mbogua J, Operario D, Mutua G, Kuo C, Mugo P, Kanungi J, Singh S, Haberer J, Priddy F, Sanders EJ. High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya. AIDS Behav. 2013;17(6):2162–72.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Poynten IM, Jin F, Prestage GP, Kaldor JM, Imrie J, Grulich AE. Attitudes towards new HIV biomedical prevention technologies among a cohort of HIV-negative gay men in Sydney, Australia. HIV Med. 2010;11(4):282–8.CrossRefPubMed Poynten IM, Jin F, Prestage GP, Kaldor JM, Imrie J, Grulich AE. Attitudes towards new HIV biomedical prevention technologies among a cohort of HIV-negative gay men in Sydney, Australia. HIV Med. 2010;11(4):282–8.CrossRefPubMed
15.
Zurück zum Zitat Mutua G, Sanders E, Mugo P, Anzala O, Haberer JE, Bangsberg D, Barin B, Rooney JF, Mark D, Chetty P, Fast P. Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers. PLoS ONE. 2012;7(4):e33103.CrossRefPubMedPubMedCentral Mutua G, Sanders E, Mugo P, Anzala O, Haberer JE, Bangsberg D, Barin B, Rooney JF, Mark D, Chetty P, Fast P. Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers. PLoS ONE. 2012;7(4):e33103.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Lorente N, Fugon L, Carrieri MP, Andreo C, Le Gall JM, Cook E, Aboulker JP, Capitant C, Molina JM, Spire B. Acceptability of an “on-demand” pre-exposure HIV prophylaxis trial among men who have sex with men living in France. AIDS Care. 2012;24(4):468–77.CrossRefPubMed Lorente N, Fugon L, Carrieri MP, Andreo C, Le Gall JM, Cook E, Aboulker JP, Capitant C, Molina JM, Spire B. Acceptability of an “on-demand” pre-exposure HIV prophylaxis trial among men who have sex with men living in France. AIDS Care. 2012;24(4):468–77.CrossRefPubMed
17.
Zurück zum Zitat Galea JT, Kinsler JJ, Salazar X, Lee SJ, Giron M, Sayles JN, Cáceres C, Cunningham WE. Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations. Int J STD AIDS. 2011;22(5):256–62.CrossRefPubMedPubMedCentral Galea JT, Kinsler JJ, Salazar X, Lee SJ, Giron M, Sayles JN, Cáceres C, Cunningham WE. Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations. Int J STD AIDS. 2011;22(5):256–62.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Eisingerich AB, Wheelock A, Gomez GB, Garnett GP, Dybul MR, Piot PK. Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. PLoS ONE. 2012;7(1):e28238.CrossRefPubMedPubMedCentral Eisingerich AB, Wheelock A, Gomez GB, Garnett GP, Dybul MR, Piot PK. Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. PLoS ONE. 2012;7(1):e28238.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Aghaizu A, Mercey D, Copas A, Johnson AM, Hart G, Nardone A. Who would use PrEP? Factors associated with intention to use among MSM in London: a community survey. Sex Transm Infect. 2013;89(3):207–11.CrossRefPubMed Aghaizu A, Mercey D, Copas A, Johnson AM, Hart G, Nardone A. Who would use PrEP? Factors associated with intention to use among MSM in London: a community survey. Sex Transm Infect. 2013;89(3):207–11.CrossRefPubMed
20.
Zurück zum Zitat Hill PC, Pargament KI. Advances in the conceptualization and measurement of religion and spirituality: implications for physical and mental health research. Am Psychol. 2003;58(1):64–74.CrossRefPubMed Hill PC, Pargament KI. Advances in the conceptualization and measurement of religion and spirituality: implications for physical and mental health research. Am Psychol. 2003;58(1):64–74.CrossRefPubMed
21.
Zurück zum Zitat Löwe B, Kroenke K, Gräfe K. Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res. 2005;58(2):163–71.CrossRefPubMed Löwe B, Kroenke K, Gräfe K. Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res. 2005;58(2):163–71.CrossRefPubMed
22.
Zurück zum Zitat Li C, Friedman B, Conwell Y, Fiscella K. Validity of the Patient Health Questionnaire 2 (PHQ-2) in identifying major depression in older people. J Am Geriatr Soc. 2007;55(4):596–602.CrossRefPubMed Li C, Friedman B, Conwell Y, Fiscella K. Validity of the Patient Health Questionnaire 2 (PHQ-2) in identifying major depression in older people. J Am Geriatr Soc. 2007;55(4):596–602.CrossRefPubMed
24.
Zurück zum Zitat Huber J, Orme B, Miller R. The value of choice simulators. In: Gustafsson A, Herrmann AF, editors. Conjoint measurement. 4th ed. New York: Springer; 2007. p. 347–62.CrossRef Huber J, Orme B, Miller R. The value of choice simulators. In: Gustafsson A, Herrmann AF, editors. Conjoint measurement. 4th ed. New York: Springer; 2007. p. 347–62.CrossRef
25.
Zurück zum Zitat Orme B. Market simulators for conjoint analysis. Getting started with conjoint analysis: strategies for product design and pricing research. 2nd ed. Madison: Research Publishers LLC; 2010. Orme B. Market simulators for conjoint analysis. Getting started with conjoint analysis: strategies for product design and pricing research. 2nd ed. Madison: Research Publishers LLC; 2010.
26.
Zurück zum Zitat Huber J, Orme B, Miller R. The value of choice simulators. In: Gustafsson A, Herrmann AF, editors. Conjoint measurement. 4th ed. New York: Springer; 2007. p. 347–62.CrossRef Huber J, Orme B, Miller R. The value of choice simulators. In: Gustafsson A, Herrmann AF, editors. Conjoint measurement. 4th ed. New York: Springer; 2007. p. 347–62.CrossRef
28.
Zurück zum Zitat World Health Organization. Policy brief: pre-exposure prophylaxis (PrEP): WHO expands recommendation on oral pre-exposure prophylaxis of HIV infection (PrEP). Geneva: World Health Organization; 2015. World Health Organization. Policy brief: pre-exposure prophylaxis (PrEP): WHO expands recommendation on oral pre-exposure prophylaxis of HIV infection (PrEP). Geneva: World Health Organization; 2015.
29.
Zurück zum Zitat Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, Tremblay C, Le Gall JM, Cua E, Pasquet A, Raffi F. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237–46.CrossRefPubMed Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, Tremblay C, Le Gall JM, Cua E, Pasquet A, Raffi F. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237–46.CrossRefPubMed
30.
Zurück zum Zitat Charpentier N, Quatremère G, Mabire X, Roduit S, Laguette V, Spittler D, Guillois E, Martin C, Castro DR, Préau M. Freins et leviers de la prise en charge du traitement post-exposition au VIH. Santé Publique. 2016;28(6):791–9.CrossRefPubMed Charpentier N, Quatremère G, Mabire X, Roduit S, Laguette V, Spittler D, Guillois E, Martin C, Castro DR, Préau M. Freins et leviers de la prise en charge du traitement post-exposition au VIH. Santé Publique. 2016;28(6):791–9.CrossRefPubMed
31.
Zurück zum Zitat Ryom L, Boesecke C, Gisler V, Manzardo C, Rockstroh JK, Puoti M, Furrer H, Miro JM, Gatell JM, Pozniak A, Behrens G. Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons. HIV Med. 2016;17(2):83–8.CrossRefPubMed Ryom L, Boesecke C, Gisler V, Manzardo C, Rockstroh JK, Puoti M, Furrer H, Miro JM, Gatell JM, Pozniak A, Behrens G. Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons. HIV Med. 2016;17(2):83–8.CrossRefPubMed
32.
Zurück zum Zitat Eisingerich AB, Wheelock A, Gomez GB, Garnett GP, Dybul MR, Piot PK. Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. PLoS ONE. 2012;7(1):e2823.CrossRef Eisingerich AB, Wheelock A, Gomez GB, Garnett GP, Dybul MR, Piot PK. Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. PLoS ONE. 2012;7(1):e2823.CrossRef
33.
Zurück zum Zitat Castro DR, Quatremere G, Sagaon-Teyssier L, Le Gall JM, Preau M, Suzan-Monti M, Spire B. Informal pre-exposure prophylaxis use in France: results from the Flash Prep survey (2014). HIV Med. 2017;18(4):308–10.CrossRef Castro DR, Quatremere G, Sagaon-Teyssier L, Le Gall JM, Preau M, Suzan-Monti M, Spire B. Informal pre-exposure prophylaxis use in France: results from the Flash Prep survey (2014). HIV Med. 2017;18(4):308–10.CrossRef
34.
Zurück zum Zitat Dubov A, Ogunbajo A, Yorik R, Altice F, Fraenkel L. Knowledge, beliefs, and willingness to prescribe PrEP among infectious disease providers in Ukraine. J Assoc Nurses AIDS Care (forthcoming). Dubov A, Ogunbajo A, Yorik R, Altice F, Fraenkel L. Knowledge, beliefs, and willingness to prescribe PrEP among infectious disease providers in Ukraine. J Assoc Nurses AIDS Care (forthcoming).
35.
Zurück zum Zitat Dubov A, Ogunbajo A, Altice, F, Fraenkel L. Optimizing access to PrEP based on MSM preferences: results of a discreet choice experiment. HIV Med (forthcoming). Dubov A, Ogunbajo A, Altice, F, Fraenkel L. Optimizing access to PrEP based on MSM preferences: results of a discreet choice experiment. HIV Med (forthcoming).
Metadaten
Titel
Strategies to Implement Pre-exposure Prophylaxis with Men Who Have Sex with Men in Ukraine
verfasst von
Alex Dubov
Liana Fraenkel
Roman Yorick
Adedotun Ogunbajo
Frederick L. Altice
Publikationsdatum
06.12.2017
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 4/2018
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-017-1996-y

Weitere Artikel der Ausgabe 4/2018

AIDS and Behavior 4/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.